Aemetis, Inc (AMTX) Rating Reiterated by B. Riley

Aemetis, Inc (NASDAQ:AMTX)‘s stock had its “hold” rating reiterated by B. Riley in a report released on Monday. They currently have a $2.00 target price on the specialty chemicals company’s stock. B. Riley’s target price suggests a potential upside of 173.97% from the company’s current price. B. Riley also issued estimates for Aemetis’ Q4 2017 earnings at ($0.25) EPS, FY2017 earnings at ($1.37) EPS, Q1 2018 earnings at ($0.26) EPS, Q2 2018 earnings at ($0.25) EPS, Q3 2018 earnings at ($0.25) EPS, Q4 2018 earnings at ($0.24) EPS and FY2018 earnings at ($1.00) EPS.

Several other research firms have also recently commented on AMTX. Zacks Investment Research raised Aemetis from a “sell” rating to a “hold” rating in a report on Tuesday, October 17th. FBR & Co reaffirmed a “neutral” rating and issued a $2.00 price target on shares of Aemetis in a report on Saturday, August 19th.

Aemetis (NASDAQ:AMTX) traded down $0.03 during trading hours on Monday, hitting $0.73. The company had a trading volume of 10,300 shares, compared to its average volume of 50,136. Aemetis has a 12-month low of $0.53 and a 12-month high of $2.50. The company has a quick ratio of 0.20, a current ratio of 0.37 and a debt-to-equity ratio of -1.87.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this article on another website, it was stolen and reposted in violation of United States and international trademark and copyright laws. The correct version of this article can be accessed at

An institutional investor recently bought a new position in Aemetis stock. Ninepoint Partners LP acquired a new position in Aemetis, Inc (NASDAQ:AMTX) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned 5.81% of Aemetis as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 18.71% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.

Receive News & Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related companies with's FREE daily email newsletter.

Leave a Reply